A carregar...

Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells

Androgen receptor (AR) signaling pathway remains the foremost target of novel therapeutics for castration-resistant prostate cancer (CRPC). However, the expression of constitutively active AR variants lacking the carboxy-terminal region in CRPC may lead to therapy inefficacy. These AR variants are s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cottard, Félicie, Asmane, Irène, Erdmann, Eva, Bergerat, Jean-Pierre, Kurtz, Jean-Emmanuel, Céraline, Jocelyn
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3642121/
https://ncbi.nlm.nih.gov/pubmed/23658830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0063466
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!